Company Ceres Pharma Romania S.r.l. with Fiscal Code 19035018
recorded a turnover of 2024 of
6.189.070,
with a net profit of
496.587
and having an average number of employees of
22.
The company operates in the field of Comerţ cu ridicata nespecializat having the NACE code 4690.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Ceres Pharma Romania S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
1.426.257
1.734.671
2.043.556
2.618.973
2.981.807
3.500.656
5.044.647
4.287.501
5.114.426
6.189.070
Total Income - EUR
1.429.135
1.737.616
2.050.693
2.657.070
2.989.267
3.506.628
5.054.557
4.316.592
5.136.446
6.206.616
Total Expenses - EUR
1.400.445
1.637.781
1.825.643
2.442.580
2.652.193
3.134.753
4.601.797
4.157.347
4.546.037
5.623.356
Gross Profit/Loss - EUR
28.689
99.835
225.050
214.490
337.074
371.874
452.760
159.245
590.408
583.260
Net Profit/Loss - EUR
20.732
78.626
184.563
178.545
283.606
312.982
383.637
133.790
501.099
496.587
Employees
11
12
15
18
18
19
19
20
21
22
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 21.7%, from 5.114.426 euro in the year 2023, to 6.189.070 euro in 2024.
The Net Profit decreased by -1.712 euro, from 501.099 euro in 2023, to 496.587 in the last year.
Check the financial reports for the company - Ceres Pharma Romania S.r.l.
Financial Rating - CERES PHARMA ROMANIA S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Ceres Pharma Romania S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Ceres Pharma Romania S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Ceres Pharma Romania S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Ceres Pharma Romania S.r.l. - CUI 19035018
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
25.055
33.940
51.624
90.388
142.465
120.695
94.619
141.522
214.335
157.398
Current Assets
829.537
896.766
897.347
1.252.488
1.441.486
2.333.643
2.646.136
2.963.172
3.406.074
3.875.881
Inventories
116.283
112.596
188.082
204.589
318.551
820.679
718.439
1.099.703
902.478
1.271.111
Receivables
618.632
714.141
658.477
975.160
1.065.786
1.272.429
1.542.412
1.516.531
2.180.539
2.292.122
Cash
94.623
70.029
50.789
72.740
57.149
240.536
385.286
346.937
323.057
312.648
Shareholders Funds
35.119
78.733
184.756
178.752
565.148
867.416
1.231.817
1.369.429
1.866.375
2.352.531
Social Capital
90
89
175
172
109.135
107.066
104.692
105.017
104.698
104.113
Debts
820.982
853.897
766.171
1.168.291
1.021.177
1.591.189
1.513.152
1.741.114
1.760.738
1.695.644
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4690 - 4690"
CAEN Financial Year
4690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
3.875.881 euro in 2024 which includes Inventories of
1.271.111 euro, Receivables of
2.292.122 euro and cash availability of
312.648 euro.
The company's Equity was valued at
2.352.531 euro, while total Liabilities amounted to
1.695.644 euro.
Equity increased by 496.587 euro, from 1.866.375 euro in 2023, to 2.352.531 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Ceres Pharma Romania S.r.l.